UH-rouen
Rouen, Seine Maritime, 76000, France
NCT Number: NCT01565577
This study aims to estimate the vaccinal immunity four years after four doses of MenbVac in children aged 4-8 years.
Looking for future studies?
Notify Me7 year–12 year
All sexes
Interventional
Phase 3
Rouen, Seine Maritime, 76000, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood test
Time frame: two and a half years after the fouth vaccination
assessment of vaccine Immunity with measure of percentage of children with an hSBA title >= 4 four years after four doses of MenbVac
University Hospital, Rouen
Other
Phase 3, Vaccinal Activity Assessment of MenBVac Against Nesseiria Menigitidis B:14,P1.7,16 Strain in Child Vaccinated With MenBVac®
Acronym: Exten MenbVac
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.